Aktis Oncology, Inc.
AKTS
$18.75
$0.030.16%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -15.14M | -12.06M | |||
| Total Depreciation and Amortization | 695.00K | 441.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 393.00K | -617.00K | |||
| Change in Net Operating Assets | -1.19M | -567.00K | |||
| Cash from Operations | -15.24M | -12.80M | |||
| Capital Expenditure | -4.15M | -2.23M | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -122.30M | -170.65M | |||
| Cash from Investing | -126.46M | -172.88M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 258.00K | 65.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | 0.00 | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -1.03M | -1.87M | |||
| Cash from Financing | -772.00K | -1.80M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -142.47M | -187.49M | |||